We offer high flexibility, technical expertise and experience to develop and produce your oral solid drug products.
Your development projects are eligible for the Research Tax Credit (CIR) up to 30% of the amount.
We have obtained the Research Tax Credit agreement from the French Ministry of Higher Education, Research and Innovation (MESRI) to execute R&D activities for third parties.
Our production systems meet current safety, environmental and quality standards, with recognized procedural knowledge in the development and manufacturing of tablets and micro-tablets.
We manage primary and secondary packaging services in blisters, bottles and kits.
Our Quality and HSE Management Systems guarantee our customers high standards of quality, safety and performance.